期刊文献+

支架置入与斑块旋切治疗TASCⅡA、B型股浅动脉病变的疗效观察

Percutaneous transluminal stenting versus directional atherectomy for lower limb artery TASCⅡ Class A and B superficial femoral artery lesions
原文传递
导出
摘要 目的探讨腔内支架置入与斑块旋切治疗下肢动脉短段病变的临床疗效及安全性。方法对我院符合泛大西洋协会指南(TASC)Ⅱ分型为A、B型股浅动脉病变的患者随机分两组纳人研究,支架置人组50例(50条动脉)和斑块旋切组50例(50条动脉).Rutherford分级3~5级。通过随访对比两组患者在技术成功率、治疗成功率、首次手术费用、通畅率、术后踝肱指数(ABI)、保肢率方面的差异。结果支架置人组与斑块旋切组技术成功率均为100%;治疗成功率分别为98%和86%(P>0.05)。术后AB1分别为0.82±0.19和0.80±0.27(P>0.05)。首次手术费[(34820±1051)元比(45635±1358)元,P<0.001],差异有统计学意义。随访6个月(98.0%比98.0%)、1年(89.8%比85.7%)及2年(73.5%比68.8%)—期累积通畅率差异均无统计学意义(P>0.05),2年二期累积通畅率(81.6%比72.9%)差异均无统计学意义(P>0.05)。保肢率(97.9%比93.8%)差异无统计学意义(P>0.05)。结论支架置入和斑块旋切治疗TASC A、B型股浅动脉病变近期疗效及安全性无明显差异。 Objective To compare the effect and safety of stenting versus directional atherectomy(DA)in the treatment of TASCⅡ A and B superficial femoral artery lesions.Methods 100 patients with TASC Ⅱ A and B lesions were divided into percutaneous transluminal stenting(PTS)group(n=50)and DA group(n=50).Patients were compared in terms of technical success rate,treatment success rate,first operation cost,postoperative ankle brachial index(ABI),limb salvage rate,survival,and patency.Results The technical success rate in both PTS and DA group was 100%.The treatment success rate was 98%vs.86%,P>0.05.Postoperative ABI:0.82±0.19 vs.0•80土0•27,P>0.05.First operation cost:(34820±1051)yuan vs.(45635±1358)yuan,p<0•001;All patients were followed-up for up to 2-year,the cumulative patency rate was 81.6%vs.72.9%(P>0.05).Limb salvage rate was 97.9%vs.93.8%,P>0.05.Conclusion There were no significant differences in the effect and safety of PTS versus DA in the treatment of TASCII A and B superficial femoral artery lesions.
作者 李津凯 孔敬波 黄梅 曹健鹏 殷述刚 戴兵 张楠 张松 赵文鲁 Li Jinkai;Kong Jingbo;Huang Mei;Cao Jianpeng;Yin Shugang;Dai Bing;Zhang Nan;Zhang Song;Zhao Wenlu(Department of Vascular Surgery,Tianjin Hospitalt Tianjin 300021,China)
出处 《中华普通外科杂志》 CSCD 北大核心 2020年第1期42-45,共4页 Chinese Journal of General Surgery
基金 天津市卫生局科技基金资助项目(2014KY30)。
关键词 外周动脉疾病 破行 股浅动脉 支架 斑块旋切 Peripheral artery disease Claudication Superficial femoral artery Stents Directional atherectomy
  • 相关文献

参考文献1

二级参考文献18

  • 1Pate1 MR, Conte MS, Cutlip DE, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: definitions from Peripheral Academic Research Consortium (PARC)[J]. J Am Coil Cardiol, 2015,65(9) :931- 941.
  • 2Rooke TW, Hirsch AT, Misra S, et al. Management of patients with peripheral artery disease (compilation of 2005 mad 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [ J ]. J Am Coil Cardiol, 2013, 61 (14) : 1555-1570.
  • 3Olin JW, White C J, Armstrong E J, et al. Peripheral Artery Disease : Evolving Role of Exercise, Medical Therapy, and Endovascular Options [ J ]. J Am Coil Cardiol, 2016,67 (11 ): 1338-1357.
  • 4Kullo IJ, Rooke TW. CLINICAL PRACTICE. Peripheral Artery Disease[J]. N Engl J Med, 2016, 374(9) :861-871.
  • 5Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC I1 ) [J]. J Vasc Surg, 2007,45 Suppl S:$5-67.
  • 6Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) [ J~. Eur Heart J, 2011,32(22) :2851-2906.
  • 7de Donato G, Bosiers M, Setacci F, et al. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions[ J]. Ann Vasc Surg, 2015,29(4) :738-750.
  • 8Klein A J, Feldman DN, Aronow HD, et al. SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use[J]. Catheter Cardiovase Interv, 2014,84(4) :520-528.
  • 9Krakenberg H, Sehltlter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm inlength: the femoral artery stenting trial (FAST) [ J]. Circulation, 2007, 116 ( 3 ) : 285 -292.
  • 10Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery [J]. NEnglJMed, 2006,354(18) :1879-1888.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部